Skip to content
Evigrade
CriticalClass III antiarrhythmics (Vaughan Williams)×Fourth-generation fluoroquinolone

Updated · Methodology

Mechanism

Moxifloxacin prolongs the QT interval on the electrocardiogram (ECG), and the effect may increase with higher drug concentrations and faster intravenous infusion (moxifloxacin summary of product characteristics, SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS; moxifloxacin label, US Food and Drug Administration, FDA). Amiodarone also prolongs the QT interval, and new arrhythmias during amiodarone treatment usually occur when drug interactions or electrolyte disturbances prolong the interval further (amiodarone SmPC, AEMPS). The Spanish moxifloxacin SmPCs do not rule out an additive effect of the two drugs on the QT interval and link it to a higher risk of ventricular arrhythmias, including torsade de pointes. Rare cases of QT prolongation, with or without torsade de pointes, have been reported in patients taking amiodarone with fluoroquinolones (moxifloxacin and amiodarone SmPCs, AEMPS). The moxifloxacin SmPC considers metabolic interactions through cytochrome P450 enzymes unlikely (AEMPS), so in the documents the risk of this pair comes from the combined effect of the two drugs on the heart. Amiodarone is eliminated very slowly, with a half-life of 15–142 days, so its interactions persist for weeks to months after it is stopped (amiodarone label, FDA).

Symptoms

QT prolongation itself causes no symptoms and shows only on an electrocardiogram (ECG). Palpitations, fast heartbeat, ventricular tachyarrhythmias, fainting with brief loss of consciousness, torsade de pointes and cardiac arrest have been reported with moxifloxacin (moxifloxacin summary of product characteristics, SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). The US label names prolonged palpitations and loss of consciousness as symptoms of QT prolongation (moxifloxacin label, US Food and Drug Administration, FDA). Amiodarone can worsen an existing arrhythmia or cause new ventricular fibrillation, incessant ventricular tachycardia and polymorphic ventricular tachycardia of the torsade de pointes type (amiodarone label, FDA). Women and older people may be more sensitive to QT-prolonging drugs, and low potassium can increase QT prolongation and the risk of torsade de pointes (moxifloxacin and amiodarone SmPCs, AEMPS).

Management

The combination is contraindicated: the Spanish moxifloxacin summaries of product characteristics (SmPCs) name amiodarone among the class III antiarrhythmics that must not be given with moxifloxacin. The SmPC of one Spanish amiodarone generic also names moxifloxacin as contraindicated (moxifloxacin and amiodarone SmPCs, Spanish Agency of Medicines and Medical Devices, AEMPS). The original Spanish amiodarone SmPC says to avoid fluoroquinolones during amiodarone treatment (AEMPS). The US amiodarone and moxifloxacin labels say to avoid this combination (amiodarone and moxifloxacin labels, US Food and Drug Administration, FDA). Amiodarone interactions can occur for several months after amiodarone is stopped (AEMPS). Moxifloxacin itself is contraindicated in documented QT prolongation, uncorrected hypokalaemia, clinically relevant bradycardia, heart failure with reduced left ventricular ejection fraction and a history of symptomatic arrhythmias (moxifloxacin SmPC, AEMPS). If signs of arrhythmia appear during moxifloxacin treatment, stop moxifloxacin, even if the electrocardiogram (ECG) shows no changes (AEMPS). Before starting amiodarone, record an ECG, measure blood potassium and correct a potassium deficit (amiodarone SmPC, AEMPS). The US label also says to correct low magnesium and calcium beforehand (FDA). If torsade de pointes occurs, do not give antiarrhythmics. Use ventricular pacing, and intravenous magnesium sulfate can also be given (amiodarone SmPC, AEMPS).

Your whole list in one report

Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email

Add more drugs

Medicine list: everything you take in one place →

Sources

Other interactions with Amiodarone

Other interactions with Moxifloxacin